home / stock / mynz / mynz short
Short Information | Mainz Biomed B.V. (NASDAQ:MYNZ)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 5,406,300 |
Total Actual Volume | 28,508,297 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 270,315 |
Average Short Percentage | 22.79% |
Is there a MYNZ Short Squeeze or Breakout about to happen?
See the MYNZ Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-23-2024 | $0.37 | $0.3549 | $0.382 | $0.3409 | 774,601 | 210,515 | 27.18% |
07-22-2024 | $0.3734 | $0.381 | $0.3943 | $0.355 | 442,379 | 89,265 | 20.18% |
07-19-2024 | $0.38 | $0.349 | $0.394 | $0.34 | 734,244 | 102,336 | 13.94% |
07-18-2024 | $0.4251 | $0.38 | $0.43 | $0.3705 | 816,401 | 226,561 | 27.75% |
07-17-2024 | $0.4166 | $0.4244 | $0.439 | $0.4011 | 528,451 | 52,165 | 9.87% |
07-16-2024 | $0.4346 | $0.4278 | $0.459 | $0.41 | 765,249 | 167,803 | 21.93% |
07-15-2024 | $0.44 | $0.432 | $0.4549 | $0.3911 | 1,143,511 | 180,954 | 15.82% |
07-12-2024 | $0.47 | $0.4778 | $0.502 | $0.425 | 1,161,464 | 332,968 | 28.67% |
07-11-2024 | $0.4048 | $0.4634 | $0.485 | $0.4 | 871,564 | 158,489 | 18.18% |
07-10-2024 | $0.469 | $0.4056 | $0.469 | $0.4 | 1,460,901 | 201,340 | 13.78% |
07-09-2024 | $0.53 | $0.4801 | $0.55345 | $0.39 | 12,281,008 | 1,330,362 | 10.83% |
07-08-2024 | $0.4259 | $0.477 | $0.5599 | $0.4095 | 3,752,353 | 1,289,427 | 34.36% |
07-05-2024 | $0.37 | $0.388 | $0.39 | $0.352 | 416,038 | 80,392 | 19.32% |
07-03-2024 | $0.3389 | $0.3351 | $0.37 | $0.33 | 204,247 | 27,219 | 13.33% |
07-02-2024 | $0.37 | $0.339 | $0.396899 | $0.3206 | 568,416 | 185,583 | 32.65% |
07-01-2024 | $0.39 | $0.3452 | $0.394749 | $0.315 | 602,240 | 145,141 | 24.1% |
06-28-2024 | $0.484 | $0.401 | $0.484 | $0.3408 | 781,562 | 274,157 | 35.08% |
06-27-2024 | $0.399 | $0.4661 | $0.47 | $0.391546 | 223,972 | 91,832 | 41% |
06-26-2024 | $0.38 | $0.396 | $0.4199 | $0.3705 | 219,778 | 41,997 | 19.11% |
06-25-2024 | $0.433 | $0.375 | $0.4621 | $0.3521 | 759,918 | 217,794 | 28.66% |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Mainz BioMed CEO Guido Baechler joined Steve Darling from Proactive to announce the company has submitted an application to the U.S. Food and Drug Administration requesting Breakthrough Device Designation for its innovative non-invasive Next Generation colorectal cancer sc...
On the basis of its positive clinical studies Mainz Biomed has now defined the final configuration including its novel mRNA biomarkers of the Next Generation Test to be used in pivotal registration study ReconAAsense A recent clinical analysis of this new configuration demonstrates sens...
BERKELEY, Calif. and MAINZ, Germany, July 02, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first six months ending June 30, 2024, and provided a cor...